Osteonecrosis Clinical Trial
Official title:
A Randomized Controlled Trial of Core Decompression With or Without Cement Packing for Osteonecrosis of the Femoral Head - Long Term Results
Osteonecrosis of the femoral head (ONFH) is difficult to treat as collapse frequently occurs after core decompression (CD). This may be due to the failure to provide structural support during revascularization and healing. Reports of polymethylmethacrylate (PMMA) packing of the femoral head after CD for ONFH have noted favorable results. This study was undertaken to determine whether the addition of PMMA packing to CD provides any benefit to progression-free survival (PFS) and conversion to total hip arthroplasty-free survival (CFS). Secondary objectives were to assess for differences in functional outcomes and predictive factors for progression of the disease.
A prospective randomized controlled trial comparing the results of CD vs. CD + PMMA packing
in pre-collapse ONFH was set up.
Consecutive symptomatic patients aged >14 years with Association Research Circulation Osseous
(ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging were enrolled in this
study.
Exclusion criteria were pre-existing collapse, sub-chondral fracture or degenerative changes
of the hip.
After obtaining informed written consent, patients are asked to complete the Harris Hip Score
(HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and a health
status questionnaire Short Form-36 (SF-36).
The femoral heads enrolled into the study are randomized using a computer-generated card draw
system to one of following: core decompression (CD) or core decompression with PMMA cement
packing (CD + PMMA).
Allocation concealment was practiced with the use of opaque envelopes. Patients with
bilateral involvement who had been randomized to one treatment modality for one femoral head
were automatically selected to receive the other treatment modality for the contralateral
femoral head.
Blinding of either surgeon or patient is impossible.
The patients were followed up after surgery every 3-4 months for the first 2 years after
which the patients were seen annually. Completed questionnaires and radiographs were obtained
at each visit.
Statistical Analysis The date of index procedure (CD or CD + PMMA) was used as start date for
the purpose of statistical analysis. Progression Free Survival was defined as the time to
radiographic progression and Conversion Free Survival (CFS) as the time to a THA. In case of
patients who did not have radiographic progression, the date of their last follow up or death
was used for the analysis. The SAS software will be used for all the analyses. The Log rank
and Gerhan-Wilcoxon tests were used to compare Kaplan-Meier survival curves for the time from
the date of the index procedure to radiographic progression (subchondral collapse) or
conversion to THA for separate groupings based on age at index procedure (<40 , >40 yrs),
smoking (Y/N), location (central, medial, lateral), percent involvement (<15% [mild], 15% to
30% [moderate], or >30% [severe]), index of necrotic extent (<40 or >40), and modified index
of necrotic extent (<40 or >40). Whenever factors were found to affect the survival curves
mainly in the initial year the Gerhan-Wilcoxon test was used as the test of significance. The
Kaplan-Meier curves were also compared for the main cohorts of CD vs. CD + PMMA. Cox
proportional hazards regression was used to compare factors (age, smoking, location, percent
involvement, index of necrotic extent, and modified index of necrotic extent) with regards to
their ability to predict the time to progression or revision to THA. Mixed multilevel
regression modeling was used to test for group differences in the change in self-rated health
survey scores over time from baseline over the post-operative period. The hierarchical linear
modeling approach has a number of advantages over traditional repeated measures approaches
for modeling change over time, including allowance for missing data and for varying
measurement times across subjects. Separate models were generated for SF-36, Harris Hip Score
and WOMAC scores over two-year and over 5-year post-operative time periods.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04072055 -
MOTO Post-marketing Surveillance Study
|
||
Terminated |
NCT02941666 -
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
|
||
Terminated |
NCT01763684 -
Oxford Signature vs. Conventional Global Study
|
N/A | |
Completed |
NCT00505219 -
Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
|
Phase 3 | |
Withdrawn |
NCT02632903 -
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
|
Phase 2 | |
Active, not recruiting |
NCT01458782 -
ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
|
N/A | |
Completed |
NCT01583465 -
Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT04401267 -
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
|
Phase 2 | |
Completed |
NCT03197623 -
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
|
Phase 1 | |
Active, not recruiting |
NCT05283148 -
Sickle Cell Disease (SCD) Bone Pain Study
|
N/A | |
Completed |
NCT05684588 -
Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
|
N/A | |
Terminated |
NCT03269409 -
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis
|
Phase 1 | |
Completed |
NCT00913679 -
A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
|
N/A | |
Enrolling by invitation |
NCT02893293 -
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
|
Phase 4 | |
Completed |
NCT01345097 -
A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients
|
Phase 4 | |
Recruiting |
NCT00260897 -
Molecular Genetic Study of Avascular Necrosis of the Femoral Head
|
N/A | |
Not yet recruiting |
NCT06016634 -
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
|
Phase 2 | |
Completed |
NCT02077647 -
Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
|
||
Recruiting |
NCT01619124 -
Osteonecroses in Pediatric Patients With ALL
|
N/A | |
Completed |
NCT02458937 -
Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
|